|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 96.27 CAD | +0.95% |
|
-2.91% | +13.62% |
| 02-17 | NUTRIEN : Gets a Neutral rating from Barclays | ZD |
| 02-16 | NUTRIEN : UBS reiterates its Neutral rating | ZD |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.02 | 6.24 | 11.77 | 4.14 | 3.1 | |||||
Return on Total Capital | 2.81 | 8.87 | 17 | 5.88 | 4.32 | |||||
Return On Equity % | 2.03 | 13.79 | 31.02 | 5.02 | 2.82 | |||||
Return on Common Equity | 2.03 | 13.7 | 30.97 | 4.94 | 2.72 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 26.13 | 35.03 | 41.67 | 30.18 | 30.1 | |||||
SG&A Margin | 16.23 | 13.51 | 10.77 | 14.34 | 16.33 | |||||
EBITDA Margin % | 16.12 | 24.16 | 31.11 | 18.99 | 18.04 | |||||
EBITA Margin % | 9 | 19.21 | 27.58 | 13.87 | 11.73 | |||||
EBIT Margin % | 7.59 | 18.04 | 26.59 | 12.65 | 10.37 | |||||
Income From Continuing Operations Margin % | 2.29 | 11.84 | 20.77 | 4.57 | 2.8 | |||||
Net Income Margin % | 2.29 | 11.74 | 20.7 | 4.48 | 2.69 | |||||
Net Avail. For Common Margin % | 2.29 | 11.74 | 20.7 | 4.48 | 2.69 | |||||
Normalized Net Income Margin | 3.33 | 10.21 | 15.97 | 6.09 | 4.01 | |||||
Levered Free Cash Flow Margin | 8.79 | 6.55 | 12.51 | 5.84 | 5.42 | |||||
Unlevered Free Cash Flow Margin | 10.27 | 7.66 | 13.33 | 7.45 | 7.13 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.43 | 0.55 | 0.71 | 0.52 | 0.48 | |||||
Fixed Assets Turnover | 1 | 1.35 | 1.77 | 1.27 | 1.11 | |||||
Receivables Turnover (Average Receivables) | 6.61 | 6.96 | 7.19 | 5.47 | 5.38 | |||||
Inventory Turnover (Average Inventory) | 2.99 | 3.1 | 3.09 | 2.81 | 2.8 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.35 | 1.11 | 1.14 | 1.17 | 1.15 | |||||
Quick Ratio | 0.59 | 0.47 | 0.5 | 0.52 | 0.52 | |||||
Operating Cash Flow to Current Liabilities | 0.39 | 0.31 | 0.57 | 0.42 | 0.29 | |||||
Days Sales Outstanding (Average Receivables) | 55.36 | 52.48 | 50.79 | 66.7 | 68.05 | |||||
Days Outstanding Inventory (Average Inventory) | 122.36 | 117.73 | 118.01 | 130.01 | 130.65 | |||||
Average Days Payable Outstanding | 104.47 | 92.89 | 87.5 | 112.36 | 114.64 | |||||
Cash Conversion Cycle (Average Days) | 73.25 | 77.32 | 81.3 | 84.35 | 84.07 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 50.79 | 45.77 | 46.12 | 49.86 | 52.4 | |||||
Total Debt / Total Capital | 33.68 | 31.4 | 31.56 | 33.27 | 34.38 | |||||
LT Debt/Equity | 48.91 | 35.68 | 34.56 | 39.33 | 40.42 | |||||
Long-Term Debt / Total Capital | 32.43 | 24.48 | 23.65 | 26.25 | 26.52 | |||||
Total Liabilities / Total Assets | 52.61 | 52.56 | 52.62 | 52.22 | 52.85 | |||||
EBIT / Interest Expense | 3.2 | 10.12 | 20.33 | 4.89 | 3.8 | |||||
EBITDA / Interest Expense | 7.39 | 14.19 | 24.49 | 7.88 | 7.22 | |||||
(EBITDA - Capex) / Interest Expense | 4.4 | 10.69 | 19.89 | 4.49 | 4.29 | |||||
Total Debt / EBITDA | 3.24 | 1.6 | 1.01 | 2.2 | 2.6 | |||||
Net Debt / EBITDA | 2.82 | 1.52 | 0.93 | 2.03 | 2.42 | |||||
Total Debt / (EBITDA - Capex) | 5.44 | 2.12 | 1.24 | 3.86 | 4.37 | |||||
Net Debt / (EBITDA - Capex) | 4.74 | 2.02 | 1.15 | 3.57 | 4.08 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 3.82 | 33.95 | 37.79 | -24.13 | -10.92 | |||||
Gross Profit, 1 Yr. Growth % | -4.78 | 79.6 | 63.93 | -45.06 | -11.14 | |||||
EBITDA, 1 Yr. Growth % | -10.37 | 100.8 | 77.4 | -53.67 | -15.41 | |||||
EBITA, 1 Yr. Growth % | -21.59 | 185.87 | 97.83 | -61.84 | -24.67 | |||||
EBIT, 1 Yr. Growth % | -25.43 | 218.4 | 103.05 | -63.89 | -27.02 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -53.73 | 592.59 | 141.81 | -83.32 | -45.4 | |||||
Net Income, 1 Yr. Growth % | -53.73 | 586.93 | 142.94 | -83.58 | -46.42 | |||||
Normalized Net Income, 1 Yr. Growth % | -29.88 | 310.22 | 115.47 | -71.07 | -41.3 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -52.6 | 585.08 | 156.88 | -82.16 | -46.25 | |||||
Accounts Receivable, 1 Yr. Growth % | -0.92 | 55.85 | 18.94 | -16.58 | -0.71 | |||||
Inventory, 1 Yr. Growth % | -0.9 | 28.36 | 20.61 | -16.98 | -2.97 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -3.32 | 1.81 | 8.75 | 3.19 | 0.64 | |||||
Total Assets, 1 Yr. Growth % | 0.84 | 5.85 | 9.27 | -3.37 | -1.72 | |||||
Tangible Book Value, 1 Yr. Growth % | -8 | 16.88 | 22.67 | -2.94 | -2.59 | |||||
Common Equity, 1 Yr. Growth % | -2.2 | 5.75 | 9.16 | -2.56 | -2.98 | |||||
Cash From Operations, 1 Yr. Growth % | -9.33 | 16.94 | 108.7 | -37.53 | -30.22 | |||||
Capital Expenditures, 1 Yr. Growth % | -17.65 | 17.78 | 25.32 | 9.41 | -16.5 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 64.8 | -0.23 | 177.65 | -64.31 | -20.65 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 49.7 | -0.07 | 152.05 | -57.25 | -17.56 | |||||
Dividend Per Share, 1 Yr. Growth % | 2.27 | 2.22 | 4.35 | 10.42 | 1.89 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.36 | 17.92 | 35.86 | 2.25 | -17.79 | |||||
Gross Profit, 2 Yr. CAGR % | -1.43 | 30.77 | 71.58 | -5.1 | -30.13 | |||||
EBITDA, 2 Yr. CAGR % | -7.32 | 34.16 | 88.74 | -9.34 | -37.4 | |||||
EBITA, 2 Yr. CAGR % | -13.78 | 49.72 | 137.81 | -13.12 | -46.39 | |||||
EBIT, 2 Yr. CAGR % | -16.27 | 54.09 | 154.27 | -14.37 | -48.67 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 284.79 | 79.02 | 309.23 | -36.5 | -69.82 | |||||
Net Income, 2 Yr. CAGR % | -64.16 | 78.28 | 308.52 | -36.83 | -70.34 | |||||
Normalized Net Income, 2 Yr. CAGR % | -20.62 | 69.6 | 197.31 | -21.04 | -58.79 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 301.43 | 80.2 | 319.51 | -32.3 | -69.03 | |||||
Accounts Receivable, 2 Yr. CAGR % | 4.85 | 24.26 | 36.15 | -0.39 | -8.99 | |||||
Inventory, 2 Yr. CAGR % | 0.13 | 12.78 | 24.42 | 0.06 | -10.25 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 2.27 | -0.79 | 5.22 | 5.93 | 1.9 | |||||
Total Assets, 2 Yr. CAGR % | 1.84 | 3.32 | 7.55 | 2.76 | -2.55 | |||||
Tangible Book Value, 2 Yr. CAGR % | -15.07 | 3.7 | 19.74 | 9.11 | -2.76 | |||||
Common Equity, 2 Yr. CAGR % | -4.31 | 1.7 | 7.44 | 3.13 | -2.77 | |||||
Cash From Operations, 2 Yr. CAGR % | 27.26 | 2.97 | 56.22 | 14.18 | -33.98 | |||||
Capital Expenditures, 2 Yr. CAGR % | 0.64 | -1.52 | 25.1 | 17.78 | -5.81 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 36.76 | 28.23 | 62.08 | -0.86 | -45.65 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 28.46 | 22.31 | 54.76 | 3.41 | -39.64 | |||||
Dividend Per Share, 2 Yr. CAGR % | 5.09 | 2.25 | 3.28 | 7.34 | 6.07 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 71.01 | 12.69 | 24.21 | 11.88 | -2.34 | |||||
Gross Profit, 3 Yr. CAGR % | 73.74 | 20.39 | 41 | 17.39 | -7.16 | |||||
EBITDA, 3 Yr. CAGR % | 35.75 | 19.92 | 47.25 | 18.18 | -11.41 | |||||
EBITA, 3 Yr. CAGR % | 43.18 | 28.57 | 64.29 | 29.22 | -17.15 | |||||
EBIT, 3 Yr. CAGR % | 36.38 | 30.69 | 68.93 | 32.66 | -18.82 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 43.91 | 368.07 | 97.89 | 40.83 | -39.61 | |||||
Net Income, 3 Yr. CAGR % | 11.97 | -4.08 | 97.65 | 39.94 | -40.21 | |||||
Normalized Net Income, 3 Yr. CAGR % | 43.78 | 37.24 | 83.69 | 36.75 | -28.47 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 64.81 | 379.72 | 102.8 | 46.43 | -37.31 | |||||
Accounts Receivable, 3 Yr. CAGR % | 97.82 | 19.66 | 22.46 | 15.64 | -0.5 | |||||
Inventory, 3 Yr. CAGR % | 84.26 | 8.77 | 15.33 | 8.72 | -0.96 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 14.87 | 2.12 | 2.29 | 4.54 | 4.14 | |||||
Total Assets, 3 Yr. CAGR % | 40.55 | 3.16 | 5.26 | 3.78 | 1.24 | |||||
Tangible Book Value, 3 Yr. CAGR % | -1.49 | -5.53 | 9.67 | 11.64 | 5.07 | |||||
Common Equity, 3 Yr. CAGR % | 39.14 | -1.07 | 4.13 | 4 | 1.05 | |||||
Cash From Operations, 3 Yr. CAGR % | 39.46 | 23.72 | 30.31 | 15.09 | -3.11 | |||||
Capital Expenditures, 3 Yr. CAGR % | 29.78 | 6.06 | 8.82 | 20.1 | 4 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 6.17 | 23.12 | 62.98 | -2.39 | -6.64 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 15.26 | 18.14 | 53.05 | 0.54 | -3.04 | |||||
Dividend Per Share, 3 Yr. CAGR % | 65.1 | 4.12 | 2.94 | 5.61 | 5.49 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 28.2 | 46.94 | 55.97 | 8.39 | 5.31 | |||||
Gross Profit, 5 Yr. CAGR % | 18.22 | 60.73 | 72.87 | 9.46 | 6.48 | |||||
EBITDA, 5 Yr. CAGR % | 6.49 | 39.83 | 54.88 | 7.23 | 4.58 | |||||
EBITA, 5 Yr. CAGR % | 1.42 | 57.47 | 75.39 | 9.91 | 4.97 | |||||
EBIT, 5 Yr. CAGR % | -1.9 | 56.33 | 74.97 | 10.35 | 4.9 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -16.26 | 74.06 | 118.6 | 110.53 | -6.74 | |||||
Net Income, 5 Yr. CAGR % | -18.42 | 57.73 | 87.9 | -18.84 | -7.44 | |||||
Normalized Net Income, 5 Yr. CAGR % | -7.28 | 69.04 | 92.26 | 10.02 | 1.03 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -9.63 | 87.66 | 139.49 | 119.19 | -4.36 | |||||
Accounts Receivable, 5 Yr. CAGR % | 45.19 | 61.59 | 70.36 | 11.2 | 8.75 | |||||
Inventory, 5 Yr. CAGR % | 45.77 | 52.47 | 57.48 | 5.2 | 4.32 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 8.27 | 8.49 | 10.91 | 3.63 | 2.14 | |||||
Total Assets, 5 Yr. CAGR % | 21.99 | 23.69 | 26.28 | 3 | 2.07 | |||||
Tangible Book Value, 5 Yr. CAGR % | -1.02 | 2.54 | 6.51 | 0.08 | 4.52 | |||||
Common Equity, 5 Yr. CAGR % | 21.69 | 23.6 | 25.47 | 0.59 | 1.31 | |||||
Cash From Operations, 5 Yr. CAGR % | 7.28 | 25.26 | 45.94 | 19.81 | -0.72 | |||||
Capital Expenditures, 5 Yr. CAGR % | 3.18 | 13.42 | 27.89 | 11.9 | 2.96 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 18.55 | 42.82 | 25.75 | 11.71 | 4.88 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 19.25 | 62.86 | 29.68 | 10.89 | 5.33 | |||||
Dividend Per Share, 5 Yr. CAGR % | 3.44 | 21.32 | 36.85 | 5.4 | 4.18 |
- Stock Market
- Equities
- NTR Stock
- Financials Nutrien Ltd.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















